KALA BIO(KALA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KALA KALA BIO

Pre-Mkt 02-24 07:01:05 EST

0.3806

+0.0006

+0.16%

High0.4191	Low0.3750	Vol368.40K
Open0.4100	D1 Closing0.3800	Amplitude11.61%
Mkt Cap346.73M	Tradable Cap346.73M	Total Shares911.00M
T/O143.84K	T/O Rate0.04%	Tradable Shares911.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KALA","market":"US","secType":"STK","nameCN":"KALA BIO","latestPrice":0.3806,"timestamp":1771880400000,"preClose":0.38,"halted":0,"volume":368403,"delay":0,"changeRate":0.0015789473684210248,"floatShares":911000000,"shares":911000000,"eps":-5.825375,"marketStatus":"Pre-Mkt","change":0.0006,"latestTime":"02-24 07:01:05 EST","open":0.41,"high":0.4191,"low":0.375,"amount":143836.87270049998,"amplitude":0.116053,"askPrice":0.42,"askSize":400,"bidPrice":0.37,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.825375,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1500523200000,"exchange":"NASDAQ","adjPreClose":0.3806,"postHourTrading":{"tag":"盘后","latestPrice":0.3782,"preClose":0.3806,"latestTime":"19:55 EST","volume":6851,"amount":2650.9318,"timestamp":1771894543725,"change":-0.0024,"changeRate":-0.006306,"amplitude":0.031266},"volumeRatio":0.6886701596407183,"impliedVol":0.9132,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/KALA","defaultTab":"news","newsList":[{"id":"2613297332","title":"Kala Bio Director David Lazar Resigns from Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297332","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297332?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:06","pubTimestamp":1771621596,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. announced that David Lazar has resigned from its board of directors, effective February 16, 2026. The company said his departure was not due to any disagreement over its operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDLc8pw1s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALA","BK4139","BK4007"],"gpt_icon":0},{"id":"2610666987","title":"Kala Bio Inc. Files Initial Statement of Beneficial Ownership for Director Yonatan C. Colman","url":"https://stock-news.laohu8.com/highlight/detail?id=2610666987","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610666987?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:16","pubTimestamp":1770671762,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing identifies Yonatan C. Colman as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL64xzCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kala Bio Inc. Files Initial Statement of Beneficial Ownership for Director Yonatan C. Colman","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALA","BK4139","BK4007"],"gpt_icon":0},{"id":"2609810385","title":"Kala Bio Inc. ernennt Avi Minkowitz zum CEO und CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609810385","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609810385?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:08","pubTimestamp":1770325718,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. hat bekannt gegeben, dass David Lazar mit sofortiger Wirkung von seinen Positionen als Chief Executive Officer und Chief Financial Officer zurückgetreten ist. Avi Minkowitz, bisher bereits Mitglied des Board of Directors, wurde zum neuen Chief Executive Officer und Chief Financial Officer des Unternehmens ernannt.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL79ddl4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALA","BK4007","BK4139"],"gpt_icon":0},{"id":"2609581440","title":"KALA BIO Inc - Avi Minkowitz Appointed as CEO and CFO of KALA BIO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2609581440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609581440?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:06","pubTimestamp":1770325604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z11G1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","KALA"],"gpt_icon":0},{"id":"2609581423","title":"KALA BIO Inc - David Lazar Resigns as CEO and CFO of KALA BIO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2609581423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609581423?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:06","pubTimestamp":1770325604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z11G1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","KALA"],"gpt_icon":0},{"id":"2606629762","title":"Kala Bio Receives Nasdaq Warning Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2606629762","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606629762?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:51","pubTimestamp":1769413890,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requirement of $1.00 per share, as its stock traded below this threshold for 30 consecutive business days. The company has been given a 180-day period, until July 20, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. If Kala Bio does not meet this requirement, it may be eligible for an additional 180-day extension if it meets other listing standards and provides written intent to resolve the deficiency, potentially through a reverse stock split. Failure to regain compliance could result in the company’s stock being delisted from Nasdaq.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL2ydmVj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALA","BK4007"],"gpt_icon":0},{"id":"2605274286","title":"KALA BIO Receives Nasdaq Notice on Listing Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2605274286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605274286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:36","pubTimestamp":1769207760,"startTime":"0","endTime":"0","summary":"KALA BIO ( ($KALA) ) just unveiled an announcement. On January 20, 2026, Kala Bio disclosed that it had received a notice from Nasdaq stating that,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kala-bio-receives-nasdaq-notice-on-listing-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kala-bio-receives-nasdaq-notice-on-listing-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4588","NQmain","BK4585","KALA","LU1169590202.USD","BK4007","BIO","LU1169589451.USD","BK4139"],"gpt_icon":0},{"id":"2602731356","title":"KALA BIO Inc - on Jan 8, Enters Agreement With H.c. Wainwright - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602731356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602731356?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:36","pubTimestamp":1767908192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","KALA"],"gpt_icon":0},{"id":"2602313198","title":"KALA BIO Launches At-the-Market Equity Offering Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313198","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313198?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:32","pubTimestamp":1767907973,"startTime":"0","endTime":"0","summary":"The latest update is out from KALA BIO ( ($KALA) ). On January 8, 2026, KALA BIO, Inc. entered into an at-the-market equity offering agreement with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kala-bio-launches-at-the-market-equity-offering-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kala-bio-launches-at-the-market-equity-offering-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4121","BIO","LU1169589451.USD","BK4215","BK4139","KALA","LU1169590202.USD","BK4007","BK4588","EQR"],"gpt_icon":0},{"id":"2601858334","title":"BRIEF-Kala Bio Settles Approximately $10.6 Million Of Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858334","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601858334?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:16","pubTimestamp":1767651368,"startTime":"0","endTime":"0","summary":"BRIEF-Kala Bio Settles Approximately $10.6 Million Of DebtKALA BIO Inc KALA.O:KALA BIO SETTLES APPROXIMATELY $10.6 MILLION OF DEBTSource text: ID:nGNX68cgWvFurther company coverage: KALA.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA7T2MFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","KALA"],"gpt_icon":0},{"id":"2601837310","title":"Kala Bio Settles $10.6 Million Debt with Oxford Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837310","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837310?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:10","pubTimestamp":1767647417,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. has announced the successful settlement of its debt obligations with Oxford Finance, LLC. By making a $2 million payment, the company has fully satisfied and discharged approximately $10.6 million in debt as of December 26, 2025. This resolution eliminates a significant financial overhang, enhancing the company’s strategic flexibility and strengthening its stockholders' equity. The settlement follows a previously disclosed agreement related to events of default under a prior loan arrangement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL5bJvSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALA","BK4139","BK4585","BK4588","NDAQ","LU2095319765.USD","BK4007","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014021.USD","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2601837393","title":"KALA BIO Settles Approximately $10.6 Million of Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837393?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:10","pubTimestamp":1767647405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA7T2MFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALA","BK4139","BK4007"],"gpt_icon":0},{"id":"2600093824","title":"KALA BIO Inc - Pays $2 Mln to Oxford Finance Llc as Part of Settlement Agreement, Settles All Obligations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2600093824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600093824?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:20","pubTimestamp":1767388841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nFWN3Y30CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALA","BK4007","BK4139"],"gpt_icon":0},{"id":"2600839093","title":"Kala Bio Inc. Settles $10.6 Million Debt with $2 Million Payment to Oxford Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2600839093","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600839093?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:16","pubTimestamp":1767388565,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. has announced that it has paid $2 million to Oxford Finance, LLC, settling all obligations under a previous loan agreement and a related settlement agreement. With this payment, Kala Bio has resolved and released an aggregate liability of approximately $10.6 million owed to Oxford.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL3Dzlzp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALA","BK4007"],"gpt_icon":0},{"id":"2595717287","title":"Kala Bio Inc. Announces Date for 2025 Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717287?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:13","pubTimestamp":1767129237,"startTime":"0","endTime":"0","summary":"Kala Bio Inc. has announced that its 2025 annual meeting of stockholders will be held virtually on January 30, 2026. During the meeting, stockholders will consider and vote on various matters, including the Oxford Settlement and Voting Agreement, delinquent Section 16 reports, and other related items. Proposals related to stockholder submissions for the 2026 annual meeting and householding of annual meeting materials will also be addressed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL2pxpV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KALA","BK4139"],"gpt_icon":0},{"id":"2593423587","title":"Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593423587","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593423587?lang=en_us&edition=fundamental","pubTime":"2025-12-24 11:12","pubTimestamp":1766545920,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics surged 64.65% in after-hours trading following a major insider investment and board appointment.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/23/Stock-Market-Analysis--Notebooks--Laptop.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/23/Stock-Market-Analysis--Notebooks--Laptop.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/12/49578047/why-did-indaptus-therapeutics-surge-64-in-after-hours-trading","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["KALA","BK4539","LENZ","BK4139","INDP","BK4007","RSI","BK4150"],"gpt_icon":0},{"id":"2589881278","title":"KALA BIO Raises $10 Million From Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2589881278","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589881278?lang=en_us&edition=fundamental","pubTime":"2025-12-06 03:56","pubTimestamp":1764964616,"startTime":"0","endTime":"0","summary":"KALA BIO  said Friday it has closed its registered direct offering of 10 million shares at $1.00 per share, raising about $10 million.Investors could also buy pre-funded warrants in lieu, the company said.KALA BIO said it plans to use the net proceeds to repay debt and for general corporate purposes.Shares of KALA BIO fell over 5% in recent trading.Price: 0.91, Change: -0.05, Percent Change: -5.29","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIO","KALA","BK4585","LU1169589451.USD","BK4139","BK4007","BK4588","LU1169590202.USD","BK4121"],"gpt_icon":1},{"id":"2588835314","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:45 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2588835314","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588835314?lang=en_us&edition=fundamental","pubTime":"2025-12-04 23:45","pubTimestamp":1764863138,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:45 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nAQN2LC3U7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","KALA"],"gpt_icon":0},{"id":"2588835397","title":"KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2588835397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588835397?lang=en_us&edition=fundamental","pubTime":"2025-12-04 23:45","pubTimestamp":1764863114,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA3BHXGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALA","BK4139","BK4007"],"gpt_icon":0},{"id":"2588835393","title":"KALA BIO Inc - Purchase Price Set at $1.00 per Share in Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2588835393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588835393?lang=en_us&edition=fundamental","pubTime":"2025-12-04 23:45","pubTimestamp":1764863114,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA3BHXGB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","KALA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kalarx.com","stockEarnings":[{"period":"1week","weight":-0.0637},{"period":"1month","weight":-0.3709},{"period":"3month","weight":-0.4037},{"period":"6month","weight":-0.9606},{"period":"1year","weight":-0.9427},{"period":"ytd","weight":-0.3153}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.01363},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.091977},{"month":3,"riseRate":0.625,"avgChangeRate":0.271513},{"month":4,"riseRate":0.375,"avgChangeRate":-0.095725},{"month":5,"riseRate":0.25,"avgChangeRate":-0.117576},{"month":6,"riseRate":0.5,"avgChangeRate":0.007868},{"month":7,"riseRate":0.375,"avgChangeRate":-0.025178},{"month":8,"riseRate":0.444444,"avgChangeRate":0.043537},{"month":9,"riseRate":0,"avgChangeRate":-0.257871},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.21893},{"month":11,"riseRate":0.555556,"avgChangeRate":0.039437},{"month":12,"riseRate":0.333333,"avgChangeRate":0.569832}],"exchange":"NASDAQ","name":"KALA BIO","nameEN":"KALA BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"KALA BIO(KALA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest KALA BIO(KALA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"KALA BIO,KALA,KALA BIO股票,KALA BIO股票老虎,KALA BIO股票老虎国际,KALA BIO行情,KALA BIO股票行情,KALA BIO股价,KALA BIO股市,KALA BIO股票价格,KALA BIO股票交易,KALA BIO股票购买,KALA BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KALA BIO(KALA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest KALA BIO(KALA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction